Metabolomics

• 

  Subject Areas on Research

  • A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration. 
  • A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates. 
  • A Multidimensional Bioinformatic Platform for the Study of Human Response to Surgery. 
  • A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product. 
  • A Roadmap for the Human Oral and Craniofacial Cell Atlas. 
  • A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. 
  • A genomic catalog of Earth's microbiomes. 
  • A guide to interrogating immunometabolism. 
  • A joint analysis of metabolomics and genetics of breast cancer. 
  • A metabolomic endotype of bioenergetic dysfunction predicts mortality in critically ill patients with acute respiratory failure. 
  • A metabolomics comparison of plant-based meat and grass-fed meat indicates large nutritional differences despite comparable Nutrition Facts panels. 
  • A reference tissue atlas for the human kidney. 
  • A resource of lipidomics and metabolomics data from individuals with undiagnosed diseases. 
  • A strategy for sensitive, large scale quantitative metabolomics. 
  • Alterations in metabolic pathways and networks in Alzheimer's disease. 
  • Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. 
  • Alternative splicing in Acad8 resulting a mitochondrial defect and progressive hepatic steatosis in mice. 
  • An atlas of genetic influences on human blood metabolites. 
  • An integrated clinico-metabolomic model improves prediction of death in sepsis. 
  • Association of Plasma Small-Molecule Intermediate Metabolites With Age and Body Mass Index Across Six Diverse Study Populations. 
  • BCAA Supplementation in Mice with Diet-induced Obesity Alters the Metabolome Without Impairing Glucose Homeostasis. 
  • Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. 
  • Best practices and lessons learned from reuse of 4 patient-derived metabolomics datasets in Alzheimer's disease. 
  • Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics. 
  • Bile acid aspiration associated with lung chemical profile linked to other biomarkers of injury after lung transplantation. 
  • Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study. 
  • Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts. 
  • Biobanking for Metabolomics and Lipidomics in Precision Medicine. 
  • Biomarkers of Diabetic Retinopathy. 
  • Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. 
  • Cardiovascular Metabolomics. 
  • Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure. 
  • Catabolism of 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl-CoAs. 
  • Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer. 
  • Cell type-specific transcriptional profiling: implications for metabolite profiling. 
  • Cerebrospinal Fluid Metabolomic Profiles Associated With Fatigue During Treatment for Pediatric Acute Lymphoblastic Leukemia. 
  • Cessation of biomechanical stretch model of C2C12 cells models myocyte atrophy and anaplerotic changes in metabolism using non-targeted metabolomics analysis. 
  • Changes in Hepatic TRβ Protein Expression, Lipogenic Gene Expression, and Long-Chain Acylcarnitine Levels During Chronic Hyperthyroidism and Triiodothyronine Withdrawal in a Mouse Model. 
  • Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy. 
  • Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer's Disease. 
  • Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging. 
  • Compartmentalized acyl-CoA metabolism in skeletal muscle regulates systemic glucose homeostasis. 
  • Comprehensive Proteomic and Metabolomic Signatures of Nontypeable Haemophilus influenzae-Induced Acute Otitis Media Reveal Bacterial Aerobic Respiration in an Immunosuppressed Environment. 
  • Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease. 
  • Cord Blood Metabolomics: Association With Newborn Anthropometrics and C-Peptide Across Ancestries. 
  • Customized Consensus Spectral Library Building for Untargeted Quantitative Metabolomics Analysis with Data Independent Acquisition Mass Spectrometry and MetaboDIA Workflow. 
  • Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas. 
  • Development and quantitative evaluation of a high-resolution metabolomics technology. 
  • Dietary Patterns among Asian Indians Living in the United States Have Distinct Metabolomic Profiles That Are Associated with Cardiometabolic Risk. 
  • Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling. 
  • Dietary branched-chain amino acid restriction alters fuel selection and reduces triglyceride stores in hearts of Zucker fatty rats. 
  • Dietary intake of palmitate and oleate has broad impact on systemic and tissue lipid profiles in humans. 
  • Dietary methionine influences therapy in mouse cancer models and alters human metabolism. 
  • Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel. 
  • Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process. 
  • Discovery of Lipidome Alterations Following Traumatic Brain Injury via High-Resolution Metabolomics. 
  • Disrupted Maturation of the Microbiota and Metabolome among Extremely Preterm Infants with Postnatal Growth Failure. 
  • Dynamic Metabolite Profiling in an Archaeon Connects Transcriptional Regulation to Metabolic Consequences. 
  • Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes. 
  • Effects of a block in cysteine catabolism on energy balance and fat metabolism in mice. 
  • Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism. 
  • Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis. 
  • Elevated metabolites of acetaminophen in cord blood of children with obesity. 
  • Emerging Technologies for Gut Microbiome Research. 
  • Enabling high-throughput biology with flexible open-source automation. 
  • Enteric microbiome metabolites correlate with response to simvastatin treatment. 
  • Evidence for brain glucose dysregulation in Alzheimer's disease. 
  • Extraction parameters for metabolomics from cultured cells. 
  • Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality. 
  • Fluorescence-activated cell sorting in plant developmental biology. 
  • From the Cover: Arsenite Uncouples Mitochondrial Respiration and Induces a Warburg-like Effect in Caenorhabditis elegans. 
  • Functional genomics of root growth and development in Arabidopsis. 
  • Gene transcription, metabolite and lipid profiling in eco-indicator daphnia magna indicate diverse mechanisms of toxicity by legacy and emerging flame-retardants. 
  • Generation and quality control of lipidomics data for the alzheimer's disease neuroimaging initiative cohort. 
  • Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality. 
  • Getting biological about the genetics of diabetes. 
  • Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma. 
  • Guidelines for Genome-Scale Analysis of Biological Rhythms. 
  • High-Resolution Metabolomics with Acyl-CoA Profiling Reveals Widespread Remodeling in Response to Diet. 
  • High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study. 
  • Highlights of the 2012 Research Workshop: Using nutrigenomics and metabolomics in clinical nutrition research. 
  • Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI). 
  • Identification of Metabolic Changes in Ileum, Jejunum, Skeletal Muscle, Liver, and Lung in a Continuous I.V. Pseudomonas aeruginosa Model of Sepsis Using Nontargeted Metabolomics Analysis. 
  • Impaired plasmalogens in patients with schizophrenia. 
  • In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms. 
  • Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression. 
  • Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics. 
  • Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature. 
  • Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers. 
  • Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease. 
  • Integrated proteomics and metabolomics suggests symbiotic metabolism and multimodal regulation in a fungal-endobacterial system. 
  • Integration of pharmacometabolomic and pharmacogenomic approaches reveals novel insights into antiplatelet therapy. 
  • Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. 
  • Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease. 
  • Integrative systems biology: an attempt to describe a simple weed. 
  • International Ring Trial of a High Resolution Targeted Metabolomics and Lipidomics Platform for Serum and Plasma Analysis. 
  • Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis. 
  • Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease. 
  • Ion mobility derived collision cross sections to support metabolomics applications. 
  • Ischemia promotes acyl-CoAs dephosphorylation and propionyl-CoA accumulation. 
  • It's about Time: Insights into the Modes of Action of Antimalarials. 
  • Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. 
  • Maternal BMI and Glycemia Impact the Fetal Metabolome. 
  • Maternal metabolic profiling to assess fetal gestational age and predict preterm delivery: a two-centre retrospective cohort study in the US. 
  • Maternal metabolites during pregnancy are associated with newborn outcomes and hyperinsulinaemia across ancestries. 
  • Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics. 
  • Metabolic Catastrophe in Mice Lacking Transferrin Receptor in Muscle. 
  • Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling. 
  • Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer's Disease. 
  • Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease. 
  • Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders. 
  • Metabolic impact of red blood cell exchange with rejuvenated red blood cells in sickle cell patients. 
  • Metabolic network failures in Alzheimer's disease: A biochemical road map. 
  • Metabolic perturbations mediated by propionyl-CoA accumulation in organs of mouse model of propionic acidemia. 
  • Metabolic profiles predict adverse events after coronary artery bypass grafting. 
  • Metabolic profiling of norepinephrine reuptake inhibitor atomoxetine. 
  • Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization. 
  • Metabolite signatures of exercise training in human skeletal muscle relate to mitochondrial remodelling and cardiometabolic fitness. 
  • Metabolome-based signature of disease pathology in MS. 
  • Metabolomic Approaches Reveal the Role of CAR in Energy Metabolism. 
  • Metabolomic Changes after Subacute Exposure to Polycyclic Aromatic Hydrocarbons: A Natural Experiment among Healthy Travelers from Los Angeles to Beijing. 
  • Metabolomic Fingerprinting of Infants Undergoing Cardiopulmonary Bypass: Changes in Metabolic Pathways and Association With Mortality and Cardiac Intensive Care Unit Length of Stay. 
  • Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure. 
  • Metabolomic Profiling to Identify Molecular Biomarkers of Cellular Response to Methotrexate In Vitro. 
  • Metabolomic Quantitative Trait Loci (mQTL) Mapping Implicates the Ubiquitin Proteasome System in Cardiovascular Disease Pathogenesis. 
  • Metabolomic analysis of insulin resistance across different mouse strains and diets. 
  • Metabolomic analysis reveals altered skeletal muscle amino acid and fatty acid handling in obese humans. 
  • Metabolomic analysis reveals extended metabolic consequences of marginal vitamin B-6 deficiency in healthy human subjects. 
  • Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet. 
  • Metabolomic and genetic associations with insulin resistance in pregnancy. 
  • Metabolomic and inflammatory signatures of symptom dimensions in major depression. 
  • Metabolomic changes in autopsy-confirmed Alzheimer's disease. 
  • Metabolomic derangements are associated with mortality in critically ill adult patients. 
  • Metabolomic differences in heart failure patients with and without major depression. 
  • Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. 
  • Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. 
  • Metabolomic profiling identifies complex lipid species and amino acid analogues associated with response to weight loss interventions. 
  • Metabolomic profiling reveals a role for caspase-2 in lipoapoptosis. 
  • Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. 
  • Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients. 
  • Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants. 
  • Metabolomics analysis identifies a lipidomic profile in treatment-naïve juvenile dermatomyositis patients vs healthy control subjects. 
  • Metabolomics and Metabolic Diseases: Where Do We Stand? 
  • Metabolomics and mass isotopomer analysis as a strategy for pathway discovery: pyrrolyl and cyclopentenyl derivatives of the pro-drug of abuse, levulinate. 
  • Metabolomics applied to islet nutrient sensing mechanisms. 
  • Metabolomics applied to the pancreatic islet. 
  • Metabolomics evaluation of early-storage red blood cell rejuvenation at 4°C and 37°C. 
  • Metabolomics in cancer research and emerging applications in clinical oncology. 
  • Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics. 
  • Metabolomics in nutrition research: biomarkers predicting mortality in children with severe acute malnutrition. 
  • Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. 
  • Metabolomics in the developmental origins of obesity and its cardiometabolic consequences. 
  • Metabolomics of Diabetic Retinopathy. 
  • Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma. 
  • Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment. 
  • Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy. 
  • Metabolomics reveals intratumor heterogeneity - Implications for precision medicine. 
  • Metabolomics to Assess Thyroid Hormone Status? 
  • Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. 
  • Metabolomics, pathway regulation, and pathway discovery. 
  • Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function. 
  • Metabolomics: A Primer. 
  • Metabolomics: a global biochemical approach to the study of central nervous system diseases. 
  • Metabolomics: insights into plant-based diets. 
  • Metabomxtr: an R package for mixture-model analysis of non-targeted metabolomics data. 
  • Methionine metabolism is essential for SIRT1-regulated mouse embryonic stem cell maintenance and embryonic development. 
  • MiMeDB: the Human Microbial Metabolome Database. 
  • Mixture model normalization for non-targeted gas chromatography/mass spectrometry metabolomics data. 
  • Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability. 
  • Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites. 
  • Multi-omics integration in biomedical research - A metabolomics-centric review. 
  • New Strategies and Challenges in Lung Proteomics and Metabolomics. An Official American Thoracic Society Workshop Report. 
  • Novel approach in LC-MS/MS using MRM to generate a full profile of acyl-CoAs: discovery of acyl-dephospho-CoAs. 
  • Novel metabolomics markers are associated with pre-clinical decline in hand grip strength in community-dwelling older adults. 
  • Novel plasma biomarkers improve discrimination of metabolic health independent of weight. 
  • Nutritional modulation of heart failure in mitochondrial pyruvate carrier-deficient mice. 
  • Obesity Genomics and Metabolomics: a Nexus of Cardiometabolic Risk. 
  • Omics approaches to discover pathophysiological pathways contributing to human pain. 
  • Opioid use affects antioxidant activity and purine metabolism: preliminary results. 
  • Opportunities-and hard work-ahead. 
  • Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study. 
  • Parallel Multi-Omics in High-Risk Subjects for the Identification of Integrated Biomarker Signatures of Type 1 Diabetes. 
  • Pathogenesis of A⁻β⁺ ketosis-prone diabetes. 
  • Peripheral serum metabolomic profiles inform central cognitive impairment. 
  • Pharmacometabolomic signature of ataxia SCA1 mouse model and lithium effects. 
  • Pharmacometabolomics Meets Genetics: A "Natural" Clinical Trial of Statin Effects. 
  • Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway. 
  • Pharmacometabolomics of statin response. 
  • Pharmacometabolomics reveals racial differences in response to atenolol treatment. 
  • Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology. 
  • Phenotypic mapping of metabolic profiles using self-organizing maps of high-dimensional mass spectrometry data. 
  • Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure. 
  • Physiological and Metabolic Changes During the Transition from Hyperthyroidism to Euthyroidism in Graves' Disease. 
  • Pigment epithelium-derived factor (PEDF) suppresses IL-1β-mediated c-Jun N-terminal kinase (JNK) activation to improve hepatocyte insulin signaling. 
  • Plasma Metabolites and Risk of Radiation-induced Esophagitis: A Secondary Analysis from a Prospective Study. 
  • Plasma MicroRNAs in Established Rheumatoid Arthritis Relate to Adiposity and Altered Plasma and Skeletal Muscle Cytokine and Metabolic Profiles. 
  • Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association. 
  • Preliminary evidence of effects of potassium chloride on a metabolomic path to diabetes and cardiovascular disease. 
  • Preoperative Serum Metabolites Are Associated With Postoperative Delirium in Elderly Hip-Fracture Patients. 
  • Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. 
  • Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. 
  • Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics. 
  • Purine synthesis promotes maintenance of brain tumor initiating cells in glioma. 
  • Quality assurance of metabolomics. 
  • Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step. 
  • RRmix: A method for simultaneous batch effect correction and analysis of metabolomics data in the absence of internal standards. 
  • Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). 
  • Realizing the Potential of Metabolomics in Heart Failure: Signposts on the Path to Clinical Utility. 
  • Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease. 
  • Recent advances in the applications of metabolomics in eye research. 
  • Renal systems biology of patients with systemic inflammatory response syndrome. 
  • Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver-Related Events in Nonalcoholic Fatty Liver Disease. 
  • Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification. 
  • Sex and race differences of cerebrospinal fluid metabolites in healthy individuals. 
  • Sialylated Milk Oligosaccharides Promote Microbiota-Dependent Growth in Models of Infant Undernutrition. 
  • Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial. 
  • Skyline for Small Molecules: A Unifying Software Package for Quantitative Metabolomics. 
  • Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics. 
  • Statistical methods in metabolomics. 
  • Systematic Molecular Phenotyping: A Path Toward Precision Emergency Medicine? 
  • TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics. 
  • Targeted Metabolomics Demonstrates Distinct and Overlapping Maternal Metabolites Associated With BMI, Glucose, and Insulin Sensitivity During Pregnancy Across Four Ancestry Groups. 
  • Targeted metabolomics and medication classification data from participants in the ADNI1 cohort. 
  • Targeted metabolomics connects thioredoxin-interacting protein (TXNIP) to mitochondrial fuel selection and regulation of specific oxidoreductase enzymes in skeletal muscle. 
  • Targeted metabolomics finds its mark in diabetes research. 
  • Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney. 
  • The Consortium of Metabolomics Studies (COMETS): Metabolomics in 47 Prospective Cohort Studies. 
  • The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association. 
  • The Pediatric Obesity Microbiome and Metabolism Study (POMMS): Methods, Baseline Data, and Early Insights. 
  • The Singapore flagship programme in translational and clinical research in psychosis. 
  • The Tara Pacific expedition-A pan-ecosystemic approach of the "-omics" complexity of coral reef holobionts across the Pacific Ocean. 
  • The current epidemiology and clinical decisions surrounding acute respiratory infections. 
  • The influence of low-carbohydrate diets on the metabolic response to androgen-deprivation therapy in prostate cancer. 
  • The role of gut microbial community and metabolomic shifts in adaptive resistance of Atlantic killifish (Fundulus heteroclitus) to polycyclic aromatic hydrocarbons. 
  • The role of metabolomics in osteoarthritis research. 
  • Transcriptomics integrated with metabolomics reveals the effect of Bisphenol F (BPF) exposure on intestinal inflammation. 
  • Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma. 
  • Untargeted metabolomics analysis of ischemia-reperfusion-injured hearts ex vivo from sedentary and exercise-trained rats. 
  • Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy. 
  • Urine and Plasma Metabolome of Healthy Adults Consuming the DASH (Dietary Approaches to Stop Hypertension) Diet: A Randomized Pilot Feeding Study. 
  • Urine tricarboxylic acid cycle signatures of early-stage diabetic kidney disease. 
  • What was old is new again: using the host response to diagnose infectious disease. 
  • Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals. 
  • maplet: an extensible R toolbox for modular and reproducible metabolomics pipelines. 
  • n-3 Canola oil effectively replaces fish oil as a new safe dietary source of DHA in feed for juvenile Atlantic salmon. 
• 

  Keywords of People

  • Arnold, Matthias, Adjunct Associate Professor in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
  • Ghadimi, Kamrouz, Associate Professor of Anesthesiology, Anesthesiology, Cardiothoracic
  • Grimsrud, Paul, Assistant Professor in Medicine, Medicine, Endocrinology, Metabolism, and Nutrition
  • Jawahar, Jay, Student, Molecular Genetics and Microbiology
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Tsalik, Ephraim, Adjunct Associate Professor in the Department of Medicine, Medicine, Infectious Diseases
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine